KPV vs Pentosan Polysulfate
A side-by-side research comparison of KPV and Pentosan Polysulfate across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | KPV | Pentosan Polysulfate |
|---|---|---|
| Full name | Lysine-Proline-Valine Tripeptide | Pentosan Polysulfate Sodium |
| Category | Healing & Recovery | Healing & Recovery |
| Status | Research compound | FDA Approved |
| Mechanism | Inhibits NF-kB signaling pathway, reduces pro-inflammatory cytokine production (TNF-α, IL-6), and modulates immune cell activation. | Acts as a glycosaminoglycan analog that coats bladder mucosa, inhibits complement activation, and stimulates proteoglycan synthesis in cartilage. |
| Molecular weight | 342.43 Da | 4000-6000 Da (average) |
| Half-life | ~2-3 hours | ~24 hours |
| Bioavailability | ~60-70% oral; higher subcutaneous | ~3-6% oral; higher via injection |
| Typical dose | 200-500 mcg per dose | 100 mg |
| Frequency | 1-2x daily | 3x daily (oral) |
| Route | Oral, topical, or subcutaneous | Oral or subcutaneous injection |
KPV reported benefits
- Potent anti-inflammatory
- Gut inflammation reduction
- Skin condition improvement
- Immune modulation
Pentosan Polysulfate reported benefits
- Bladder wall protection
- Cartilage repair support
- Anti-inflammatory action
- Joint pain reduction
Related comparisons
Research and educational reference only. Not medical advice.